Auxological and metabolic effects of long-term treatment with recombinant growth hormone in children born small for gestational age: a retrospective study

Rosario Ferrigno,Maria Cristina Savanelli,Daniela Cioffi,Valeria Pellino,Antonella Klain
DOI: https://doi.org/10.1007/s12020-023-03665-4
2024-01-13
Endocrine
Abstract:Children born small for gestational age (SGA) not showing catch-up during the first two years of life reportedly show an impaired growth rate and adult height, as well as a worse metabolic outcome, mainly in terms of glycemic and lipid profile, compared to general population. In SGA children with short stature, treatment with recombinant growth hormone (GH) is currently recommended until adolescence; therefore, it may last long-term.
endocrinology & metabolism
What problem does this paper attempt to address?